APOE and Alzheimer disease: The sex- and race-specific effects have important implications for ongoing AD clinical trials, where APOE has been included as a screening criterion in some trials, and both outcomes and adverse events (such as amyloid-related imaging abnormalities) have been reported to differ by APOE genotype in previous trials.24,25,26,27,28